Publication of Human Genome Papers Prompts Debate over Assemblies | GenomeWeb

As expected, last week’s simultaneous publication of Celera’s and the Human Genome Project’s sequencing papers sparked a flurry of debate over the relative strength of the two assembly methods and the quality of the resulting data.

Proponents of the public effort were quick to point out that Celera relied much more heavily upon data from the Human Genome Project than it had originally claimed, and that the bulk of the analysis in Celera’s Science paper was derived from its compartmentalized shotgun assembly rather than its whole genome assembly.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.